Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism 5-HT1B receptor antagonists(Serotonin 1b (5-HT1b) receptor antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acute Myeloid Leukemia | Preclinical | AT | 28 Feb 2024 | |
Myelodysplastic Syndromes | Preclinical | AT | 28 Feb 2024 |